Clinical trial

A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)

NCT00482079

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-05-13

PhasePHASE2

Study timeline

Study start (actual)2003-05-13Date precision: day

Registry last updated2017-03-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type IIunresolved

Interventions

MK0431, sitagliptin phosphate / Duration of Treatment: 21 WeeksDRUG

Comparator: placebo (unspecified) / Duration of Treatment: 21 WeeksDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00482079 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.